Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05444_nanopub.RA5wBoGxLp0DEZrr7U7IzLVvxay-27qSLrCHb0IvQ7B9g#assertion>. }
Showing items 1 to 14 of
14
with 100 items per page.
- drugbank:DB05444 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05444 label "BRX-235 [drugbank:DB05444]" assertion.
- drugbank:DB05444 seeAlso DB05444 assertion.
- drugbank:DB05444 description "BRX-235 (iroxanadine) is a a novel small molecule synthesized by Biorex, Hungary that acts as a cardioprotective agent. It induces phosphorylation of p38 SAPK, which plays an important role in EC homeostasis. endothelial cell (EC). EC function plays a central role in vascular diseases (e.g. atherosclerosis, restenosis, diabetic angiopathies, microvascular angina, peripheral arterial disease). BRX-235 also causes translocation of calcium-dependent protein kinase C isoform to membranes." assertion.
- drugbank:DB05444 identifier "drugbank:DB05444" assertion.
- drugbank:DB05444 title "BRX-235" assertion.
- drugbank:DB05444 drugbank_vocabulary:x-pubchemcompound pubchem.compound:6421776 assertion.
- drugbank:DB05444 drugbank_vocabulary:x-chemspider chemspider:4927305 assertion.
- drugbank:DB05444 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05444 drugbank_vocabulary:drugbank-id "DB05444" assertion.
- drugbank:DB05444 bio2rdf_vocabulary:x-identifiers.org DB05444 assertion.
- drugbank:DB05444 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05444" assertion.
- drugbank:DB05444 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05444 bio2rdf_vocabulary:identifier "DB05444" assertion.